Merck Serono to discontinue clinical development programme of tecemotide
The results of the recent trial in Japanese patients decreased the probability of current studies to reach their goals
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark’s TRPA1 antagonist shows positive data
TRPA1 is an ion channel expressed on peripheral and spinal sensory neurons and it mediates pain signal transmission
Bone Therapeutics receives clearance
To investigate Allob’s potential to improve spinal fusion surgery outcomes
The politics behind pharma
Prime Minister Modi’s decision to review India’s position on IP laws before his first trip to the US has once again brought this…
Indian generic pharma and global regulatory challenges
Dr Gopakumar G Nair, Chief Executive Officer, Gopakumar Nair Associates talks about why the regulatory scenario in the domestic…
Pharma marketing In need of a reboot
Will China’s recent crackdown on the pharmaceutical industry’s unethical marketing practices result in any long lasting changes?…
Code of conduct: A pill to cure corrup
Unethical means of promotion employed by pharma firms have underlined the importance of a Uniform Code of Pharmaceutical Marketing…
Adopting new avenues
Pharma marketing is undergoing a metamorphosis, aided by digital technology which has not only opened up new vistas for brand…
‘Quality is a philosophy regardless of geographies’
Dr Alexandra Pearce, Senior Vice President and Head Global Regulatory Affairs - Glenmark Pharmaceuticals, talks about the…